-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Cidara Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2018 to Q3 2024.
- Cidara Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -2.45 USD/shares, a 21.3% decline year-over-year.
- Cidara Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -20.5 USD/shares, a 348% decline year-over-year.
- Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.26 USD/shares, a 45.8% increase from 2022.
- Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.48 USD/shares, a 40.7% increase from 2021.
- Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -0.81 USD/shares, a 55% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)